Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
William Raymond Herzog
Clinical Associate in the Department of Medicine
Medicine, Cardiology
william.herzog@duke.edu
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
Training & Certifications
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
expertise {hide_children: true, active: false, enabled: false}
Expertise
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity
Clinical Trial
Principal Investigator ·
Awarded by Novo Nordisk, Inc. ·
2019 - 2024
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Clinical Trial
Principal Investigator ·
Awarded by CSL Behring LLC ·
2019 - 2024
A Phase 3, Multicenter, Open-Label, Single-Arm Study of PB2452 in Ticagrelor-Treated Patients with Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure
Clinical Trial
Principal Investigator ·
Awarded by PhaseBio Pharmaceuticals, Inc. ·
2020 - 2023
A Phase 2 Randomized, Double-blind, Placebo-controlled, Proof of Concept Study to Evaluate the Safety and Efficacy of Antroquinonol in Hospitalized Patients with Mild to Moderate Pneumonia due to COVID-19
Clinical Trial
Principal Investigator ·
Awarded by Golden Biotechnologies Corporation ·
2021 - 2023
HEART-FID
Clinical Trial
Principal Investigator ·
Awarded by American Regent ·
2020 - 2023
A Phase III Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized Subjects with COVID-19
Clinical Trial
Principal Investigator ·
Awarded by Suzhou Kintor Pharmaceuticals, Inc. ·
2022 - 2022
DIAMOND
Clinical Trial
Principal Investigator ·
Awarded by Relypsa, Inc. ·
2020 - 2022
cvMOBIUS
Clinical Trial
Principal Investigator ·
Awarded by Amgen, Inc. ·
2020 - 2021
Care OptimizatioN through PatieNt and hospital Engagement Clinical Trial for Heart Failure
Clinical Trial
Principal Investigator ·
Awarded by Novartis Pharmaceuticals Corporation ·
2018 - 2021
CHAMP-HF
Research
Principal Investigator ·
Awarded by Novartis Pharmaceuticals Corporation ·
2016 - 2020
TACT2
Clinical Trial
Principal Investigator ·
Awarded by Mount Sinai Medical Center ·
2019 - 2019
